ARWR Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Arrowhead Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 65.6199 USD -0.46% Market Closed

Market Cap: $9.2B

	Arrowhead Pharmaceuticals Inc NASDAQ:ARWR	US
	FDM Group (Holdings) PLC LSE:FDM	UK
	Roche Holding AG LSE:0TDF	CH
	Breville Group Ltd ASX:BRG	AU
L	Liton Technology Corp TPEX:6175	TW
	SJM Holdings Co Ltd KRX:025530	KR
P	Public Service Enterprise Group Inc SWB:PSE	US
I	ITH Corp TWSE:6962	KY
	MilDef Group AB F:8QA	SE
	Laurentian Bank of Canada TSX:LB	CA

Profitability Summary

Arrowhead Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-34%

Negative 3Y Average Operating Margin

-3 866%

Operating Margin is Increasing

-70% > -34%

Negative Net Margin

-48%

Negative 3Y Average Net Margin

-3 912%

Net Margin is Increasing

-71% > -48%

Negative Free Cash Flow Margin

-11%

Negative 3Y Average Free Cash Flow Margin

-3 686%

Free Cash Flow Margin is Increasing

-134% > -11%

Negative ROE

-65%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-66%

ROIC is Increasing

-55% > -52%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.